Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.

Raghav K, Mhadgut H, McQuade JL, Lei X, Ross A, Matamoros A, Wang H, Overman MJ, Varadhachary GR.

PLoS One. 2016 May 12;11(5):e0154985. doi: 10.1371/journal.pone.0154985. eCollection 2016.

2.

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.

Kodaira M, Yonemori K, Shimoi T, Yoshida A, Yoshida M, Kitano A, Shimomura A, Yunokawa M, Shimizu C, Takiguchi Y, Fujiwara Y, Tamura K.

BMC Cancer. 2018 Feb 13;18(1):176. doi: 10.1186/s12885-018-4092-4.

3.

A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.

Shaw PH, Adams R, Jordan C, Crosby TD.

Clin Oncol (R Coll Radiol). 2007 Feb;19(1):87-95.

PMID:
17305260
4.

Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.

Riihimäki M, Thomsen H, Hemminki A, Sundquist K, Hemminki K.

BMC Cancer. 2013 Jan 28;13:36. doi: 10.1186/1471-2407-13-36.

5.

Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.

Fukushima T, Ogura K, Akiyama T, Takeshita K, Kawai A.

BMC Musculoskelet Disord. 2018 Aug 18;19(1):297. doi: 10.1186/s12891-018-2217-1.

6.

Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.

Lazaridis G, Pentheroudakis G, Fountzilas G, Pavlidis N.

Cancer Treat Rev. 2008 Dec;34(8):693-700. doi: 10.1016/j.ctrv.2008.05.005. Epub 2008 Jun 26. Review.

PMID:
18584969
7.

New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.

Trivanović D, Petkovic M, Stimac D.

Clin Oncol (R Coll Radiol). 2009 Feb;21(1):43-8. doi: 10.1016/j.clon.2008.09.007. Epub 2008 Oct 30.

PMID:
18976894
8.

Prognostic factors in cancer of unknown primary site.

Fernandez-Cotarelo MJ, Guerra-Vales JM, Colina F, de la Cruz J.

Tumori. 2010 Jan-Feb;96(1):111-6.

PMID:
20437867
9.

[Analysis of prognostic factors in 68 patients with cancer of unknown primary site].

Kou XG, Liang DL, Zhang QQ, Li XR, Zhao YZ, Gu JF, Lu P.

Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):783-6. Chinese.

PMID:
22335913
10.

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.

Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI.

Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):795-803. Review.

PMID:
10098435
11.

Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.

Oweira H, Petrausch U, Helbling D, Schmidt J, Mannhart M, Mehrabi A, Schöb O, Giryes A, Decker M, Abdel-Rahman O.

World J Gastroenterol. 2017 Mar 14;23(10):1872-1880. doi: 10.3748/wjg.v23.i10.1872.

12.

Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.

Kim CS, Hannouf MB, Sarma S, Rodrigues GB, Rogan PK, Mahmud SM, Winquist E, Brackstone M, Zaric GS.

Acta Oncol. 2015 Nov;54(10):1781-7. doi: 10.3109/0284186X.2015.1020965. Epub 2015 Mar 31.

PMID:
25825957
13.

Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.

Stokes W, Amini A, Maroni PD, Kessler ER, Stokes C, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG.

J Pediatr Urol. 2017 Aug;13(4):386.e1-386.e7. doi: 10.1016/j.jpurol.2016.12.009. Epub 2017 Jan 17.

PMID:
28153774
14.

Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.

Keegan TH, Grogan RH, Parsons HM, Tao L, White MG, Onel K, Horn-Ross PL.

Thyroid. 2015 Jun;25(6):635-48. doi: 10.1089/thy.2015.0021. Epub 2015 Apr 20.

15.

Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.

Ponce Lorenzo J, Segura Huerta A, Díaz Beveridge R, Giménez Ortiz A, Aparisi Aparisi F, Fleitas Kanonnikoff T, Richart Aznar P, de la Cueva Sapiña H, Montalar Salcedo J.

Clin Transl Oncol. 2007 Jul;9(7):452-8.

PMID:
17652059
16.

Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.

Seve P, Ray-Coquard I, Trillet-Lenoir V, Sawyer M, Hanson J, Broussolle C, Negrier S, Dumontet C, Mackey JR.

Cancer. 2006 Dec 1;107(11):2698-705.

17.

p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.

McDowell LJ, Young RJ, Johnston ML, Tan TJ, Kleid S, Liu CS, Bressel M, Estall V, Rischin D, Solomon B, Corry J.

Cancer. 2016 Apr 15;122(8):1201-8. doi: 10.1002/cncr.29901. Epub 2016 Feb 16.

18.

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.

Pentheroudakis G, Greco FA, Pavlidis N.

Cancer Treat Rev. 2009 May;35(3):221-7. doi: 10.1016/j.ctrv.2008.10.003. Epub 2008 Nov 28. Review.

PMID:
19046817
20.

Carcinoma of unknown primary: retrospective study of 437 patients treated at Salah Azaiez Institute.

Fehri R, Rifi H, Alboueiri A, Malouche D, Ayadi M, Rais H, Mezlini A.

Tunis Med. 2013 Mar;91(3):205-8.

Supplemental Content

Support Center